Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Gillespie

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
European Journal of Medicinal Chemistry|November 7, 2016
Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitorsWenlin Huang, Zhongsheng Zhang, Ximena Barros-Álvarez, et al.
Biochimie|April 22, 2017
Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterpartsXimena Barros-Álvarez, Keshia M Kerchner, Cho Yeow Koh, et al.
Journal of the American Society of Nephrology : JASN|January 5, 2017
Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique PhenotypeSamih H Nasr, Surendra Dasari, John R Mills, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapyKayode K Ojo, J Robert Gillespie, Aaron J Riechers, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
ACS Infectious Diseases|September 15, 2016
5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase InhibitorsZhongsheng Zhang, Cho Yeow Koh, Ranae M Ranade, et al.
Journal of Biomolecular Screening|August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screeningLaura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
Plos Neglected Tropical Diseases|April 19, 2014
Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sicknessCho Yeow Koh, Jessica E Kim, Allan B Wetzel, et al.
Journal of Molecular Biology|February 6, 2010
Crystal structures of trypanosomal histidyl-tRNA synthetase illuminate differences between eukaryotic and prokaryotic homologsEthan A Merritt, Tracy L Arakaki, J Robert Gillespie, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in MiceSayaka Shibata, J Robert Gillespie, Angela M Kelley, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
European Journal of Medicinal Chemistry|November 7, 2016
Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitorsWenlin Huang, Zhongsheng Zhang, Ximena Barros-Álvarez, et al.
Biochimie|April 22, 2017
Leishmania donovani tyrosyl-tRNA synthetase structure in complex with a tyrosyl adenylate analog and comparisons with human and protozoan counterpartsXimena Barros-Álvarez, Keshia M Kerchner, Cho Yeow Koh, et al.
Journal of the American Society of Nephrology : JASN|January 5, 2017
Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique PhenotypeSamih H Nasr, Surendra Dasari, John R Mills, et al.
Antimicrobial Agents and Chemotherapy|July 23, 2008
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapyKayode K Ojo, J Robert Gillespie, Aaron J Riechers, et al.
Molecular Microbiology|March 4, 2008
Characterization of Trypanosoma brucei dihydroorotate dehydrogenase as a possible drug target; structural, kinetic and RNAi studiesTracy L Arakaki, Frederick S Buckner, J Robert Gillespie, et al.
ACS Infectious Diseases|September 15, 2016
5-Fluoroimidazo[4,5-b]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase InhibitorsZhongsheng Zhang, Cho Yeow Koh, Ranae M Ranade, et al.
Journal of Biomolecular Screening|August 29, 2014
Identification of potent inhibitors of the Trypanosoma brucei methionyl-tRNA synthetase via high-throughput orthogonal screeningLaura Pedró-Rosa, Frederick S Buckner, Ranae M Ranade, et al.
Plos Neglected Tropical Diseases|April 19, 2014
Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sicknessCho Yeow Koh, Jessica E Kim, Allan B Wetzel, et al.
Journal of Molecular Biology|February 6, 2010
Crystal structures of trypanosomal histidyl-tRNA synthetase illuminate differences between eukaryotic and prokaryotic homologsEthan A Merritt, Tracy L Arakaki, J Robert Gillespie, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Selective inhibitors of methionyl-tRNA synthetase have potent activity against Trypanosoma brucei Infection in MiceSayaka Shibata, J Robert Gillespie, Angela M Kelley, et al.
Pageof 7